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ABSTRACT

A low-cost compact fiberless diffuse speckle contrast flowmeter includes a small laser diode and a 2-dimensional
imaging device such as a charge coupled device (CCD) or
complementary metal oxide semiconductor (CMOS) for
directly contacting the tissue and measuring a parameter
such as blood flow in a deep/thick volume of tissue (up to 10
mm depth). The small laser diode is fixed at a certain
distance (0 to 20 mm) from the imaging device and directly
contacts the tissue. Light emitted from the laser diode
penetrates through the tissue and reflects back to the imaging
device without passing through any lenses or fibers. One or
more additional laser diodes may be added for producing
light at different wavelengths, and the combination of measurements taken by the imaging device at the different
wavelengths allows for measuring additional parameters,
such as both blood flow and blood oxygenation.
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COMPACT LOW-COST FIBERLESS DIFFUSE
SPECKLE CONTRAST FLOW-OXIMETER

There have been a few recent technical advancements
towards BF measurements in deep tissues with coherent NIR
point-source illumination and high sensitive CCD detection
(e.g., electron multiplication CCD (EMCCD)), where the
diffuse speckle contrast spectroscopy/tomography extracts
deep tissue BF information using the relationship between
diffuse speckle contrast parameters and DCS/DCT theory.
Hundreds of detectors provided by the CCD significantly
improve the spatial and temporal resolution and reduce the
instrumentation cost and dimension. In these measurement
setups, a CCD sensor is generally connected with optical
lenses or optical fibers to detect diffuse speckle contrast
variations induced by the motion of red blood cells in the
tissue (i.e., blood flow). A long-coherence length laser or a
small laser diode are usually coupled to a lens system or an
optical fiber to deliver NIR light to the target tissue. However, these noncontact (through optical lenses) or seminoncontact measurements (through optical lenses and optical fibers) with lasers and CCD cameras make the
measurements very sensitive to motion artifacts and ambient
light. In addition, EMCCDs and long-coherence length
lasers used are still quite expensive and large.
There are very few tools available for continual bedside
assessment of neonatal brain health, which can be impacted
by the PDA and associated treatment procedures. Transcranial Doppler (TCD) probe is the commonly used bedside
method to evaluate cerebral blood flow velocity (CBFV) in
large arteries, but this method is difficult to perform continuously on neonatal heads and may not agree with CBF in
local cerebral microvasculature. Near-infrared spectroscopy
(NIRS) provides a continuous measurement of tissue oxygenation saturation (StO 2 ) in local cerebral microvasculature. However, there is a critical need for more evidence
concerning sensitivities and accuracies before applying
these measurements to clinical practice. A more recently
developed method of near-infrared DCS provides a direct
cerebral blood flow (CBF) measurement in local cerebral
microvasculature. DCS monitors temporal speckle fluctuations resulting from moving red blood cells (RBCs) and has
proven to be a valid assessment of CBF variations in the
brains of adults and children. DCS has been combined with
NIRS into hybrid instruments for simultaneous measurements of StO 2 and CBF, which allows for the derivation of
cerebral metabolic rate of oxygen (CMRO 2 ). For example,
a hybrid NIRS/DCS instrument was used to longitudinally
obtain data from premature neonates' brains and results
showed a steady decrease in StO 2 and steady increases in
CBF and CMRO 2 during the first six weeks oflife, which are
in qualitative agreement with physiological expectations.
Also, in an animal model of neonatal brain injury, it has been
shown that CMRO 2 , and not StO 2 , correlated with the
duration of cerebral ischemia. These results suggest that
multiple hemodynamic/metabolic variables provide more
comprehensive assessment of neonatal brain health than a
single parameter alone. However, as with blood flow measurements, the use of DCS in measuring other parameters
retains the shortcomings noted above.
Accordingly, a need has been identified for a system for
measuring multiple hemodynamic/metabolic variables, such
as blood flow and blood oxygenation measurements in deep
tissues, including through the skull, which addresses these
and other shortcomings of current technologies.

This application claims priority to U.S. PROVISIONAL
Application Ser. No. 62/365,119, filed Jul. 21, 2016, the
disclosure of which is hereby incorporated by reference.

5

TECHNICAL FIELD
This invention generally relates to a device for noninvasively measuring tissue blood flow and oxygenation, and
more particularly, to a compact fiberless diffuse speckle
contrast flow-oximeter for measuring blood flow and oxygenation at relatively deep tissues below skin level.
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15

BACKGROUND OF THE INVENTION
The measurements of blood flow (BF) and oxygenation
alterations in the tissue helps characterize many diseases
representing with tissue ischemia and hypoxia such as
cerebral vascular disease, peripheral artery disease, and
cancer. For example, more than 4 million babies are born
annually in the United States and -11 % of those (440,000)
are born premature and admitted to neonatal intensive care
units (NICU s). The total societal economic cost of preterm
birth is estimated at 26 billion dollars including medical
costs, early intervention, special education services, and lost
household and labor market productivity. Although significant progress has been made in the care of preterm infants,
they continue to suffer from significant morbidities and
comorbidities. Approximately 65% of infants born between
25 and 28 weeks of gestational age (GA), and 85% of those
born at GA of <24 weeks have patent ductus arteriosus
(PDA) at first week of life. PDA leads to shunting of blood
between the systemic and the pulmonary circulations, which
is associated with adverse outcomes including prolonged
assisted ventilation and higher rates of death, bronchopulmonary dysplasia, pulmonary hemorrhage, necrotizing
enterocolitis, impaired renal function, intraventricular hemorrhage, periventricular leukomalacia, and cerebral palsy.
Because of these associated complications, the majority of
infants at GA of s28 weeks receive medical or surgical
therapy in an attempt to close the PDA. Currently, the gold
standard for PDA diagnosis is echocardiography, but often
clinical symptoms are not associated with echocardiography
findings.
Compared to large imaging modalities such as computed
tomography (CT), magnetic resonance imaging (MRI), and
positron emission tomography (PET) for BF measurements,
optical instruments are relatively portable, fast, continuous,
and inexpensive. Optical techniques based on dynamic light
scattering are the most common methods for BF measurements including laser speckle contrast imaging (LSCI) and
diffuse correlation spectroscopy/tomography (DCS/DCT).
Each technique, however, has key issues that limit its
application. LSCI uses wide-field illumination and chargecoupled-device (CCD) detection of spatial laser speckle
contrasts to achieve rapid high-resolution 2-D mapping of
blood flow in superficial tissues (depth <l mm). By contrast.
DCS/DCT uses coherent near-infrared (NIR) point-source
illumination and single-photon-counting avalanche photodiodes (APDs) to accommodate spectroscopic or tomographic measurements of BF variations in deep tissues (up
to -15 mm). However, the use of expensive long-coherence
length lasers (e.g. DL785-120, Crystalaser) andAPDs (e.g.
SPCM-NIR, Pacer) limits its spatial-temporal resolution and
increases instrumentation cost.
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An object of the disclosure is to provide a probe for use
in measuring a hemodynamic parameter within a tissue of a
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subject. For example, the hemodynamic parameter may be
blood flow and/or blood oxygenation through the tissue. The
probe may include a laser diode for emitting light into the
tissue of the subject, and a bare imaging device adapted to
contact the tissue of the subject and receive light reflected
from the tissue to detect diffuse speckle contrast variations
in the tissue for measurement of the hemodynamic parameter. The bare imaging device may be a 2-dimensional array
imaging device.
In one aspect, the probe may include no optical fiber. This
may include no optical fiber associated with the laser diode
or the bare imaging device.
The laser diode may emit near-infrared light at a fixed
wavelength. This fixed wavelength may range from 700-900
nm for the measurement of blood flow. For example, the
wavelength may be 785 nm. The laser diode may produce a
short coherence length through human tissue. For example,
the coherence length of the laser diode may be 10 cm-100
cm. The laser diode may be adapted to contact the tissue of
the subject.
In a further aspect, the probe may include a retainer for
retaining the laser diode and the bare imaging device at fixed
positions relative to each other. For example, the laser diode
and the bare imaging device may be fixed relative to one
another at a distance of between O and 20 mm. In one
embodiment, this distance may be between 13 mm and 18
mm. The retainer may comprise a pad, such as a foam pad,
or a plate. The retainer may include one or more receivers,
such as holes, apertures, or recesses, for retaining the laser
diode and the bare imaging device.
The bare imaging device may be adapted to receive the
light diffused and reflected from the tissue without passing
through any lenses prior to receiving the light. Accordingly,
the imaging device may be considered "bare," as it may
contact the tissue of the subject.
The probe may further include or be adapted to connect
with a controller for controlling the function of the bare
imaging device. The controller may be remote from the bare
imaging device. For example, in the case of the use of a
retainer, the controller may not be in contact with the
retainer. In one aspect, the controller may be connected to
the bare imaging device via electrical wires. In another
aspect, the controller may be wirelessly connected to the
bare imaging. The controller may comprise a computer, a
laptop, or other mobile device.
The bare imaging device may comprise a charge coupled
device. In another aspect, the bare imaging device may
comprise a complementary metal oxide semiconductor. In
one aspect, one or more heat sinks and/or a fan may be
connected to the bare imaging device for dissipation of heat.
In another embodiment, a probe is disclosed for use in
measuring at least one hemodynamic parameter within a
tissue of a subject. The probe may comprise a first laser
diode adapted for emitting light into the tissue of the subject
at a first wavelength, and a second laser diode adapted for
emitting light into the tissue of the subject at a second
wavelength different from the first wavelength. The probe
may further include a bare imaging device adapted to
contact the tissue of the subject and receive light diffused
and reflected from the tissue to detect diffuse speckle contrast variations in the tissue for measurement of the at least
one hemodynamic parameter. The probe may additionally
include a retainer adapted to receive and maintain a constant
distance from each of the first laser diode and the second
laser diode to the bare imaging device, said retainer including a contact surface adapted to contact the tissue of the

subject, and may be further adapted to maintain the bare
imaging device in contact with the tissue with no lens
therebetween.
In one aspect, the probe includes no optical fiber.
The bare imaging device may comprise a charge coupled
device. In another aspect, the bare imaging device may
comprise a complementary metal oxide semiconductor.
One or more heat sinks may be provided to assist in
dissipating heat produced by the bare imaging device. For
instance, one or more heat sinks may be in contact with the
bare imaging device. In another aspect, a fan may be
included for heat dissipation with respect to the bare imaging device. In another aspect, a low-power imaging device
may be included without the need of heat dissipation.
In a further embodiment, a method is disclosed for
measuring at least one hemodynamic parameter within a
tissue of a subject. The method may include emitting light at
a first wavelength from a first laser diode into the tissue
without fiber coupling, said light not received through an
optical cable, placing a bare imaging device in contact with
the tissue with no lens therebetween, and measuring
reflected light from the tissue to detect diffuse speckle
contrast variations in the tissue in order to measure the at
least one hemodynamic parameter. The first laser diode may
produce a short coherence length (e.g. 10 cm-100 cm) when
said light is emitted directly without fiber coupling through
the tissue.
In one aspect, the method may further include the step of
emitting light at a second wavelength from a second laser
diode into the tissue. In this aspect, the measuring step may
comprise measuring reflected lights from the tissue from the
first laser diode and the second laser diode.
In a further aspect, the method may include the step of
attaching each of the first laser diode and the bare imaging
device to a retainer in order to maintain a fixed distance
therebetween. In the instance of the inclusion of the second
laser diode, the method may include attaching the second
laser diode to the retainer in order to maintain a fixed
distance between the second laser diode and the bare imaging device. The fixed distance from the first laser diode
(and/or from the second laser diode) to the bare imaging
device may be between O and 20 mm, or more narrowly,
between 13 mm and 18 mm.
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FIG. 1 is a schematic of a contact diffuse speckle contrast
flowmeter (DSCF) probe;
FIG. 2 illustrates an imaging device of the DSCF of FIG.
1;
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FIG. 3 is a schematic of a validity test of the imaging
device of the DSCF probe of FIG. 1 in a tissue-simulating
phantom, as compared to a contact diffuse correlation spectroscopy (DCS) probe and a non-contact imaging device
probe;
FIG. 4 is a schematic of a first dual contact probe used in
the validity test of FIG. 3;
FIGS. Sa-Sc are Bland-Altman plots illustrating the
results of the validity test in a tissue-simulating phantom of
FIG. 3;
FIG. 6 is a schematic of a validity test of a laser diode of
the DSCF of FIG. 1 in a tissue-simulating phantom;
FIG. 7 is a schematic of a second dual contact probe used
in the validity test of FIG. 6;
FIGS. Sa-Sc are Bland-Altman plots illustrating the
results of the validity test of FIG. 6;
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FIG. 9 is a forearm of a subject with a third dual contact
probe testing the validity of the laser diode with the imaging
device of the DSCF of FIG. 1;
FIG. 10 is a schematic of the third dual contact probe of
FIG. 9;
FIG. lla is a plot of the time course ofrelative blood flow
data measured concurrently by the imaging device of the
DSCF and a DCS probe in the forearm before, during, and
after the occlusion;
FIG. llb is a Bland-Altman plot illustrating the results of
the validity test of FIG. 9;
FIG. 12 is a schematic of a third dual contact probe for
testing the validity of a low-power complementary metal
oxide semiconductor (CMOS) based imaging device of a
DSCF;
FIG. 13a is a plot of the time course ofrelative blood flow
data measured concurrently by the CMOS based imaging
device of FIG. 12 and a DCS probe in the forearm before,
during, and after occlusion;
FIG. 13b is a plot of the relative blood flows of the DCS
probe against the CMOS based imaging device of FIG. 12;
FIG. 14 illustrates the use of a DCS probe and a DSCF
probe on an infant skull with a filled tissue-simulating liquid
phantom;
FIG. 15a is a plot of the relative flow changes as measured
by the DSCF probe against those as measured by the DCS
probe as calculated by a linear algorithm;
FIG. 15b is a plot of the relative flow changes as measured
by the DSCF probe against those as measured by the DCS
probe with a S-D distance of 15 mm as calculated by
conventional semi-infinite solutions;
FIG. 15c is a plot of the relative flow changes as measured
by the DSCF probe against those as measured by the DCS
probe with a S-D distance of 10 mm as calculated by
conventional semi-infinite solutions;
FIG. 16 is a schematic of a contact dual-wavelength
diffuse speckle contrast flow-oximeter (DSCFO); and
FIG. 17 illustrates the use of the dual-wavelength DSCFO
of FIG. 16 on an infant cranium.

wavelengths of 785 nm and 854 nm for measuring oxygenation). More laser diodes (>2) can be used to improve
measurement accuracy. The laser diode 12 may have a short
coherence length.
In one aspect, the bare imaging device 14 may comprise
a sensor, a chip, or a combination of the two. For instance,
the bare imaging device 14 may comprise a bare imaging
chip 20 (which may be a CCD chip or a CMOS chip),
including a bare imaging sensor 22 (which may be a CCD
sensor or a CMOS sensor), approximately 40x32 mm2 , with
a resolution of 1296x964 pixels. In a further aspect, the
imaging device 14 may include no lenses. The lack oflenses
indicates that the bare imaging device 14, including the bare
imaging sensor chip 20, may be directly placed on the tissue
surface S for contact measurements of BF variations in deep
tissues (e.g. approximately up to 10 mm below tissue
surface, such as for example, 8 mm below tissue surface). In
other words, the bare imaging device may be described as a
contact sensor because it may contact the tissue through
which BF is measured.
One embodiment of the DSCF probe 10 is illustrated in
FIG. 1. As illustrated, the DSCF probe 10 may be placed on
the surface S of turbid media M (e.g., tissue phantoms or
human tissues) for flow measurements. The laser diode 12
may act as a light source, and may be placed a known
distance away from the bare imaging device 14. For
example, the laser diode 12 may be placed at a known
distance away from an imaging sensor 22 ( e.g. a CCD sensor
or CMOS sensor) of the bare imaging device 14. As illustrated, this distance may be between X 1 and X 2 . This
distance may be referred to as the source-detector (S-D)
distance. In one aspect of the invention, the S-D distance
may vary from Oto 20 mm, or more narrowly from 13 mm
to 18 mm. Based on photon diffusion theory, NIR light
penetration depth in tissues is approximately one half of the
S-D distance. This is because light transport through tissue
is diffuse rather than straightforward. Therefore, penetration
depth of light and the ability to take measurements based
thereon depend on the S-D separation distance (i.e. about
halfofthe S-D separation). The range ofS-D separation that
may be used depends on the arrangement of the laser diode
12 and the imaging device 14, as well as the light intensity
and imaging device sensitivity. In the present invention,
typical S-D distances may be from 0 mm-20 mm. Therefore,
the penetration depth may be from 0 mm-10 mm.
A retainer 16 may be provided for maintaining relative
position between the laser diode 12 and the bare imaging
device 14. The retainer 16 may be in the form of a pad, a
plate, a block, or a film, which may include one or more
receivers for receiving the laser diode 12 and the bare
imaging device 14. For example, the retainer 16 may comprise a foam pad with an aperture or retaining space for each
of the laser diode 12 and the bare imaging device 14. In one
aspect, a thin film may be provided (not pictured) to prevent
the bare imaging sensor 22 and/or the bare imaging chip 20
from being shorted by the turbid media M.
With further reference to FIG. 2, one embodiment of the
bare imaging device 14 is illustrated. The imaging device 14
may include the bare imaging sensor 22 and the bare
imaging chip 20, which may be located at the bottom of the
bare imaging device 14, such as for being placed in contact
with the surface of the tissue to be measured. The bare
imaging chip 20 may operate as a plurality of flow detectors.
For example, each window of7x7 pixels may act as a single
detector. This may allow a single bare imaging chip 20 to
include hundreds of detectors. The bare imaging chip 20
may be connected and controlled by an external controller,
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DETAILED DESCRIPTION OF THE
INVENTION
The description provided below and in regard to the
figures applies to all embodiments unless noted otherwise,
and features common to each embodiment are similarly
shown and numbered.
In one aspect, the current disclosure identifies a low-cost
compact fiberless diffuse speckle contrast flowmeter
(DSCF) in order to measure blood flow. The DSCF may
comprise a probe 10 including a laser diode 12 and a bare
imaging device 14. This bare imaging device 14 may
comprise a 2-dimensional array imaging device. For
example, the bare imaging device 14 may comprise a
charge-coupled device (CCD) or a complementary metal
oxide semiconductor (CMOS) imaging device.
The use of a small laser diode 12, especially one with a
short coherence length, allows for use of the probe without
a fiber optic cable. For purposes of this disclosure, the term
"short coherence length" is anything with a coherence length
between 10 cm-100 cm. In one aspect, the laser diode may
output a wavelength of between 700 and 900 nm (e.g. 785
nm), at a power of below 25 mW, and may have a diameter
of 5.6 mm (e.g. L785P25, Thorlabs, NJ). A wavelength of
700-900 nm (e.g. 785 nm) may be used for measuring blood
flow, and two laser diodes with different wavelengths may
be used for measuring a different tissue parameter (e.g.
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such as a computer, a laptop, or other mobile device. In one
aspect, the connection may be through a Universal Serial
Bus cable (not shown).
One issue with a CCD or CMOS based contact measurement is that some CCD or CMOS chips may accumulate
heat. This accumulation of heat from a bare imaging sensor/
chip, which is directly contacted to the surface of target
media, could cause discomfort to a subject or may interfere
with probe efficacy. In order to spread the heat that may be
generated by a CCD or CMOS chip, multiple small heat
sinks 24 may be included. The heat sinks may be in the form
of a plate or fin. The heat sinks 24 may be attached, such as
by a thermal compound, to the integrated circuits of the
imaging chip. For example, the heat sinks may be approximately 6x6 mm2 . A fan 26 may also be included for further
enhancing heat dissipation. One or more additional heat
sinks, such as a 40x40 mm heat sink, may be connected to
the fan 26 to further assist in heat dissipation.
In another aspect, the potential accumulation of heat may
be addressed by the use of an imaging device 14 with a low
power consumption. For example, a small CMOS sensor
may be used, such as the MU9PM-MBRD, by Ximea, which
has a typical power consumption of0.6 W. Another example
of a CMOS chip is the NanEye by Awaiba, with a power
consumption as low as 4.2 mW. With a small, low-power
CMOS sensor, the size of the DSCF probe may be minimized to 6x8 mm2 (e.g. using "L785P25" as a laser diode
and "NanEye" as imaging device; S-D distance is set as
minimal) and the generated heat may be significantly
reduced. As a result, the new DSCF probe can work properly
without using sinks/fans for heat dissipation.
The laser diode 12 may be inserted into a socket (e.g.
S7060R, Thorlabs, NJ) and may be powered by a constantcurrent driver (e.g. LDC 205C, Thorlabs, NJ). The laser
diode 12 may oscillate in a single transverse mode, and may
support multiple longitudinal modes. In one aspect, the laser
diode 12 would not be expected to exhibit a long coherence
length. However, few mode lasers have complex correlation
functions that are not well described by a single coherence
length. To assess this, the laser diode 12 may be placed in a
Michelson interferometer and operated under the same conditions as in the DSCF probe 10 (constant 50 mA drive
current with no active temperature stabilization). When this
was done with the laser diode identified herein, highvisibility (>0.8) fringes were observed at many path-length
differences between O and 400 mm (limit oftest). Thus, the
laser's coherence is entirely sufficient for the S-D separations described herein.
One distinction between a CCD or CMOS based imaging
device of the DSCF and the APD detection in DCS is the
transition from measurements of slower temporal speckle
fluctuations with sufficient signal-to-noise ratio (i.e. hundreds of milliseconds for DCS probes) to faster spatial
speckle fluctuations (i.e. a few milliseconds for the DSCF
probe). To measure speckle fluctuations, lasers with certain
coherence length are needed. In general, the coherence
length of a laser must be longer than the photon path length
throughout the tissue, which is generally several time (e.g.
five times for muscles) longer than the distance between the
source and the detector. For example, the maximal S-D
distance for the DSCF may be approximately 20 mm, so a
laser diode for a DSCF probe should have a coherence
length of approximately 10 cm at least.
In order to catch up with the slower temporal fluctuations
(i.e. mathematically calculating the temporal autocorrelation
function), DCS uses a laser with a coherence length longer
than several meters (which has been experimentally deter-

mined). The long coherence length requirement makes the
laser required for DCS larger in dimension (so that it cannot
be placed on the tissue directly) as well as expensive. The
light from such long coherence length lasers must also be
passed through an optical fiber. However, an optical fiber is
rigid and lacks flexibility desired for a probe that may
positionally manipulated easily.
By contrast, DSCF measures fast spatial speckle fluctuations within only about 5 ms, mathematically calculating
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where 0 is the spatial standard deviation and ( 1) is the
mean intensity in a 7x7 pixel window). Therefore, a laser
diodes with a coherence length longer than tens of centimeters can be used for DSCF. Most laser diodes meet this
specification. For purposes of this disclosure, a laser diode
for use with a DSCF probe need only have a low coherence
length (i.e. greater than 10 cm, but less than 100 cm). And
laser diodes are significantly smaller in size than a laser with
long coherence length required for a DCS probe. Therefore,
the laser diode can be placed directly on the tissue of a
subject without the use of any optical fibers. Another advantage to the use of a bare CCD or CMOS as compared to a
larger APD is the elimination of fiber coupling. The size of
an APD is large and cannot be placed directly on the tissue.
So the APD has to be connected to an optical fiber as well.
The bare CCD or CMOS does not require any such optical
fiber. This provides flexibility in the DSCF probe that is not
available in a DCS probe, while still allowing for accuracy
of measurements.
In order to calibrate/validate the DSCF probe 10, concurrent flow measurements on liquid tissue phantoms against a
noncontact CCD-based diffuse speckle contrast probe and a
standard contact DCS probe were conducted. The liquid
tissue phantom comprised distilled water, India ink, and
Intralipid, which has been commonly used for the calibration of flow measurement techniques. India ink is used to
manipulate the absorption coefficient µa while Intralipid
provides particle Brownian motion (flow) and control of the
reduced scattering coefficient µ;. The absorption coefficient
was set to µa =0.03 cm- 1 and µ)=8 cm- 1 at 785 nm to mimic
the property of biological tissues. Flow variations of Intralipid particles were created by changing the phantom temperature. The temperature of the phantom was initially set up
to 70° C. by an immersed heater (CH103, Ovente, Calif.),
and then decreased naturally until reaching the room temperature of -22° C. A thermometer sensor (Physitemp, NJ)
was placed inside the liquid tissue phantom for temperature
measurements.
An example of a representative schematic for a phantom
experiment for testing the validity and accuracy of the DSCF
is shown in FIG. 3. This phantom experiment was designed
to compare the results obtained concurrently from the contact measurements using two different contact probes (i.e.,
DSCF and DCS) and a noncontact measurement using
another CCD camera with optical lenses (e.g., FL3-FW20S4M-C, Point Grey, BC, Canada). As shown in FIG. 3, a
dual contact probe element 30 includes both the bare imaging device 14 of the DSCF (in this instance a CCD), as well
as a detector fiber 32 to an APD (not illustrated) to utilize
DCS. In addition, a noncontact CCD camera 36 was utilized,
which included multiple lenses 38 for focusing and manipulating light source.
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Due to the use of DCS for validation, a long-coherence
length DCS laser 34 (e.g. DL785-100, CrystaLaser, NV;
wavelength: 785 run, coherence length: >5 m, power: 100
mW, dimensions: 135x36x30 mm3 , price: >$7K) was utilized. The DCS laser 34 delivered NIR light to the liquid
tissue phantom P via a customized 1x2 fiber-based beam
splitter (e.g. Fiberoptic Systems, CA). A single-mode detector fiber (e.g. SM800-5.6-125, Fibercore, CA) connected to
a 4-channel APD module (e.g. SPCM-AQ4C, PerkinElmer,
CA; dimensions: 150x130x34 mm3 , price: >$11K) and a
4-channel autocorrelation board (e.g., Flex0lLQ-05, Zhu,
Jixiang, NJ; price: -$13K) was used to collect the diffused
light for the contact DCS measurement as a gold standard for
comparisons. An identical S-D distance Y was used for all
three probes for consistency, and in this instance, an S-D
distance of 15 mm was used in all three probes. The
placement of the bare imaging device 14 (with its CCD
detector 46, comprising a set of7x7 pixels of the CCD) and
the DCS detector fiber 32, each with respect to the long
coherence length DCS laser 34 for the contact probes, can be
seen in FIG. 4. During the calibration/validation procedure,
thirty data points (DCS) or frames (CCDs) were concurrently collected within 15 seconds (i.e., 2 Hz sampling rate)
by the three probes at each of three different temperatures
(65° C., 45° C., and 25° C.). The two CCDs worked in
parallel with the same exposure time of 5 ms. Room light
was turned off during these measurements.
For standard DCS data analysis, flow index was extracted
by fitting the autocorrelation curve whose decay rate
depended on the motion of moving Intralipid particles. For
DSCF data analysis, as described above, the spatial speckle
contrast (K) over a selected window of 7x7 pixels was
determined by calculating the ratio of standard deviation (a)
and mean (µ) over these 49 pixels; i.e., K=a/µ. Flowinduced speckle fluctuation resulted in the reduction of laser
speckle contrast in space for a given exposure time. Flow
index was extracted via a nonlinear relationship between the
Kand flow index under semi-infinite geometry. To increase
the signal-to-noise ratio (SNR) of flow detection, a 3x3
adjacent pixel window array (covering an area of - 78
µmx78 µm) with nine values of K were averaged representing one DSCF detector. The detector center was chosen at 15
mm away from the laser source, allowing a penetration
depth of -8 mm. Relative flow changes were calculated by
normalizing flow data at all measurement steps (i.e., 65° C.,
45° C., and 25° C.) to the averaged flow index (assigning
100%) at the last step (25° C.).
Bland-Altman plot analysis was used to determine the
agreement between different measurements and MannWhitney u-test was used to test the systematic difference in
mean values between the measurements (i.e., the fixed bias).
FIGS. Sa-Sc show Bland-Altman plots for the comparisons
between the two of three flow measurements by the three
optical probes. Specifically, FIG. Sa illustrates a comparison
of the contact DSCF probe and the non-contact CCD probe.
FIG. Sb illustrates a comparison of the contact DSCF probe
and the contact DCS probe. FIG. Sc illustrates a comparison
of the non-contact CCD probe and the contact DCS probe.
The y-axis shows the difference between the two paired
measurements (A-B) and the x-axis shows the mean value of
these measurements (A+B)/2. The horizontal solid line
represents the mean value of (A-B) and horizontal dashed
lines represent the mean values of (A-B)±l.96xstandard
deviation of (A-B). For a good agreement between two
measurements, approximately 95% of the differences are
expected to be less than 1.96 standard deviation. Good limits
of agreement among these measurements (95.6% in FIG. Sa,

97.8% in FIG. Sb, and 100.0% in FIG. Sc) were observed.
This experiment demonstrated that the contact and noncontact CCD-based diffuse speckle contrast measurements of
flow changes generated highly consistent results (FIG. Sa),
each of which also significantly agreed with the standard
contact DCS measurement results (FIG. Sb and FIG. Sc).
A second phantom experiment, a representative schematic
for which is shown in FIG. 6, was designed to compare the
results obtained by the short coherence length laser diode 12
for DSCF and the long-coherence laser 34 for standard DCS.
Therein, a dual contact probe 30' includes the bare imaging
device 14 (again, in this case a CCD) of the DSCF probe 10
and the corresponding short coherence length laser diode 12.
In addition, the dual contact probe 30' includes the long
coherence length DCS laser 34 for use with the DCS
detector fiber 32, which is connected to an APD (not
illustrated) to utilize DCS. The dual contact probe 30' was
placed in contact with a surface of the liquid tissue phantom
P.
As illustrated in FIG. 7, the short coherence length laser
diode 12 was placed at an identical S-D distance from the
CCD detector 46 of the bare imaging device 14 as the long
coherence length DCS laser was placed from the DCS
detector fiber 32. This identical S-D distance is shown as Y'
in FIG. 7. For the purposes of this second phantom experiment, Y' was set to 15 mm.
Experimental protocols, data collection, and data analyses
were similar to those described above. For each measurement at certain temperature (i.e. 65° C., 45° C., and 25° C.),
two lasers were turned on alternatively and thirty data points
were collected in parallel by the DSCF and DCS detectors
at the sampling rate of 2 Hz.
FIGS. Sa-Sc show the Bland-Altman analysis between the
two of three flow measurements by different compositions of
sources and detectors. Specifically, FIG. Sa illustrates a
comparison of the short coherence length laser diode 12
used with the DSCF probe and the long coherence length
laser 34 used with the DSCF probe (i.e. the bare CCD 14).
FIG. Sb illustrates a comparison of the short coherence
length laser diode 12 used with the DCS detector fiber 32
and the long coherence length laser 34 used with the DCS
detector fiber 32. FIG. Sc illustrates a comparison of the
short coherence length laser diode 12 used with the DSCF
probe (i.e. the bare imaging device 14 using a CCD) and the
long coherence length laser 34 used with the DCS detector
fiber 32. Good limits of agreement among these measurements (94.4% in FIG. Sa, 94.4% in FIG. Sb and 96.7% in
FIG. Sc) were observed with no significant bias (p>0.05 in
Mann-Whitney u-tests ). This experiment demonstrated that
these two lasers (i.e., short coherence length laser diode 12
and long coherence length laser 34) generated consistent
results for the measurements of flow changes with both the
DSCF detector (FIG. Sa) and the standard DCS detector
(FIG. Sb). The consistency between the DSCF probe (i.e.,
short coherence length laser diode 12 used with bare CCD
14) and standard DCS probe (i.e., long coherence length
laser 34 used with DCS detector fiber 32 and APD) measurements of flow changes (FIG. Sc) validated the new
device and methodology (i.e., use of the DSCF probe).
Further validation measurements in human tissues have
also been conducted. A healthy subject was asked to sit and
extend his right forearm on a table. With reference to FIG.
9, a dual contact probe 30", including the bare imaging
device 14 (again using a CCD) of the DSCF probe as well
as the DCS detector fiber 32 and APD of a standard DCS
probe was utilized on the right forearm of the subject in
order to measure concurrent BF measurements. The dual

5

10

15

20

25

30

35

40

45

50

55

60

65

US 10,842,422 B2
11

12

contact probe 30" included a foam pad for receiving the bare
imaging device 14, the DCS detector fiber 32, and the short
coherence length laser diode 12, as shown in FIG. 10. As
shown in FIG. 9, the dual contact probe 30" and an arterial
cuff were attached to the arm of the subject. An arterial
cuff-occlusion (230 mmHg) paradigm was applied on subject's right upper arm to induce significant BF changes in the
right forearm. The occlusion protocol included a 3-minute
baseline, a 3-minute cuff inflation, and a 3-minute recovery
period following the cuff deflation. The sampling rates for
both DSCF and DCS measurements were set as 1 Hz (lower
than the 2 Hz in tissue phantom experiments) in order to
improve SNRs of BF measurements in human tissues. Data
analyses were similar to those described in the tissue phantom experiments, and are illustrated in FIG. lla and 1 lb.
Relative blood flow (rBF) changes were normalized to the
mean value of baseline BF data before the cuff-occlusion
(assigning 100%).
FIG. lla shows the time course rBF data measured
concurrently by the DSCF and DCS probes in the forearm
before, during, and after the occlusion. The relatively lower
limit of agreement observed in the forearm measurement
(92.8% in FIG. llb), as compared to those in the phantom
tests, was likely due to heterogeneous reactive responses of
blood flow in different regions/volumes of the forearm tissue
measured by different probes. No significant bias was
observed between the two measurements (p>0.05 in the
Mann-Whitney u-test).
Similar validation protocols were followed with respect to
the use of the imaging device 14 using the smaller, lowpowered CMOS device as described above, for reduced heat
generation. Illustrations of the validation experiment of the
CMOS based imaging device 14 are illustrated in FIGS. 12
and 13a-13b. Therein, a healthy volunteer was asked to sit
and extend his forearm on a table, as is illustrated in FIG. 9.
A dual probe 30"' included the CMOS imaging device 14'
and a standard DCS probe, both confined by a foam pad and
taped on the forearm's surface for concurrent blood flow
measurements. The S-D distance of 15 mm was used for
both DSCF and DCS measurements (i.e. between both the
laser diode 12 and CMOS imaging device 14' as well as
between the DCS laser 34 and the detector fiber 32 to the
APD). The CMOS imaging device 14' and the detector fiber
32 to the APD for use with DCS were place 60 mm apart.
An arterial cuff-occlusion (230 mmHg) was applied on the
upper arm to induce blood flow changes in the forearm. The
relative blood flow (rBF) data before, during, and after the
arterial occlusion are shown in FIG. 13a. As expected, a
significant correlation (R2 =0.89, p<l0- 5 ) and an excellent
linear relationship (slope: 1.07%, intercept: 12.00%)
between the DSCF and DCS measurements of rBF were
observed (FIG. 13b). Bland-Altman analysis showed no
significant bias with a good limit of agreement (93.9%),
which is similar to our previous result (92.8%).
In order to evaluate the ability of the DSCF probe 10 to
make transcranial measurements through the superficial
tissues of a head (e.g., infant skull), comparison measurements were conducted using the DSCF probe 10 and a
standard DCS probe in a head-simulating phantom (FIG.
14). A realistic human infant skull (31 weeks of age) was
kept inverted and filled with a turbid liquid solution mimicking the brain tissue. The homogenous liquid phantom
comprised distilled water, India ink, and Intralipid, which
has been extensively used for optical instrument calibrations. India ink is used to manipulate the absorption coefficient µa while Intralipid provides particle Brownian motion
(flow) and control of the scattering coefficient µ;. Flow

variations of Intralipid particles were created by changing
the phantom temperature, which was monitored by a thermocouple sensor (Physitemp) placed inside the phantom.
The temperature was initially set up to -50° C. by an
immersed heater, and then decreased naturally until it
reached -30° C.
The data collected by the DSCF probe 10 (placed on the
bottom of the inverted skull, FIG. 14) with two S-D distances (10 and 15 mm) at 8 different temperatures were
analyzed using layer algorithms to correct partial volume
artifacts from the skull (FIG. 15a) and compared to the
conventional semi-infinite solutions with the S-D distances
of 15 mm (FIG. 15b) and 10 mm (FIG. 15c), respectively.
The layer algorithms are described in the following publications, the disclosures of which are incorporated herein by
reference: 1) Shang Y, Li T, Chen L, Lin Y, Toborek Mand
Yu G, Extraction of diffuse correlation spectroscopy flow
index by integration of Nth-order linear model with Monte
Carlo simulation, Applied Physics Letters. 2014, 104:
193703; and 2) Shang Y and Yu G, A Nth-order linear
algorithm for extracting diffuse correlation spectroscopy
blood flow indices in heterogeneous tissues, Applied Physics
Letters, 2014, 105:133702. The semi-infinite solutions are
described in the following publications, the disclosures of
which are incorporated herein by reference: 1) Shang Y,
Cheng R, Dong L, Ryan S J, Saha S P and Yu G, Cerebral
monitoring during carotid endarterectomy using near-infrared diffuse optical spectroscopies and electroencephalogram, Phys Med Biol., 2011; 56:3015-3032; 2) Cheng R,
Shang Y, Hayes D, Saha S P and Yu G, Noninvasive optical
evaluation of spontaneous low frequency oscillations in
cerebral hemodynamics, Neuroimage, 2012; 62:1445-1454;
and 3) Cheng R, Shang Y, Wang SQ, Evans J M, Rayapati
A, Randall D C and Yu G, Near-infrared diffuse optical
monitoring of cerebral blood flow and oxygenation for the
prediction of vasovagal syncope, J Biomed Opt., 2014; 19.
A fusiform shell matching the skull dimensions was used
for Monte Carlo simulations required for the layer algorithms. The li.rBF values were then compared to the "true"
flow variations measured by the DCS probe (placed directly
on the surface of Intralipid solution through the foramen
magnum, FIG. 14) with a single S-D distance of 8 mm. A
better correlation between DSCF and DCS measurements
was observed with the layer algorithms (FIG. 15a) compared to the semi-infinite solutions without the correction of
partial volume artifacts (FIG. 15b and FIG. 15c). As
expected, partial volume artifacts from the skull had less
influence on the measurements with larger S-D distance
(FIG. 15b) than those with shorter distance (FIG. 15c).
Bland-Altman analysis showed no significant bias with good
limits of agreement for the layer algorithms (100%) and
semi-infinite solutions at larger-distance (100%) and at
shorter distance (87.5%).
These results demonstrate high consistency between
DSCF and DCS measurements of flow changes in the human
tissue and infant-head-simulating phantoms. Importantly,
DSCF flow measurements with multiple S-D distances (such
as may be provided by a high-resolution CMOS pixel array)
can be performed transcranially through the superficial
infant skull and the partial volume artifacts from the top
skull layer can be significantly reduced using the linear layer
algorithms noted above.
In contrast to noncontact CCD-based diffuse speckle
contrast probes, the DSCF probe 10 allows for contact
measurements of tissue BF variations, which can avoid
potential motion artifacts and ambient light influence
occurred in noncontact measurements. The major difference
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between the noncontact CCD detection scheme and contact
DSCF is the way to use CCD: the noncontact CCD detection
scheme uses a CCD camera with lenses without touching the
tissue whereas the contact DSCF probe 10 uses a bare CCD
chip 20 in contact with the tissue surface. The noncontact
CCD probe with a zoom lens provides the flexibility to
change the magnification and resolution of imaging, but
should not affect the detection of BF. Therefore, the principles of noncontact CCD detection scheme and contact
DSCF are essentially the same. The consistent results from
our noncontact and contact CCD measurements of flow
variations (FIG. Sa) support the commonality of these
principles.
Compared to conventional contact DCS probes which
commonly use rigid optical fibers for light delivery and
detection, the compact DSCF probe 10 can be placed
directly on the tissue surface without using any optical fiber.
The connections between the DSCF probe and a control unit
(including a driver for the laser diode and a laptop for CCD
operation) are all electrical wires/cables, which provide the
flexibility for probe installation and offer the potential for
remotely longitudinal monitoring of tissue BF variations
through wireless data transferring. Moreover, using an inexpensive laser diode 12 with a short coherence length and
bare imaging chip 20 (such as a CCD or CMOS), the cost of
a DSCF probe 10 significantly less than a conventional
4-charmel DCS flowmeter that uses a long-coherence laser,
a 4-channel APD module, and a 4-channel autocorrelator
board (e.g. approximately $1,300 as compared to approximately $23,000). The cost-efficiency can be improved even
more when conducting tomographic measurements as the
single imaging chip ofDSCF probe provides multiple detectors for image reconstruction.
In a further aspect of the invention, the DSCF technique
can be extended to the use of multiple wavelengths to
simultaneously measure multiple parameters, such as cerebral hemodynamic and metabolic parameters. These may
include blood flow, blood oxygenation, oxygenation variations, StO 2 , and CMRO 2 , in deep tissues. This may be
accomplished by using two or more laser diodes at different
wavelengths. This results in a low-cost compact diffuse
speckle contrast flow-oximeter (DSCFO). The principles of
the DSCFO are similar to the DSCF, as indicated below.
The DSCFO may comprise a DSCFO probe 110 including
at least two laser diodes 112a and 112b, and a bare imaging
device 114, as illustrated in FIG. 16. The laser diodes may
output light at different wavelengths. The wavelengths may
correspond to one or more particular parameters to be
measured. For example, a first laser diode 112a may output
a wavelength of 690 nm, at a power of30 mW, and may have
a diameter of 5.6 mm (e.g. HL6738MG, Thorlabs, NJ),
while the second laser diode 112b may output a wavelength
of 830 nm, at a power of 50 mW, and may have a diameter
of 5.6 mm (e.g. HL8338MG, Thorlabs, NJ). The use of two
laser diodes at such wavelengths may form a dual-wavelength flow-oximeter, which may maximize the sensitivity
of StO 2 measurements. This is due to the different optical
absorption characteristics of oxy-hemoglobin (HbO 2 ) vs.
deoxy-hemoglobin (Hb ). Other combinations of wavelengths may be used, such as 785 nm and 854 nm for
measuring both blood flow and oxygenation.
The bare imaging device 114 may comprise a 2-dimensional array, such as a CCD or CMOS. In one aspect, the
bare imaging device 114 comprises a CMOS chip (e.g.
MU9PM-MBRD, Ximea), which may offer a 2592x1944
pixel array and may allow for an effective frame rate of 14
images per second. A 7x7 region of sensor pixels is the

minimum requirement for conducting an effective BF measurement. Utilizing various subsets of pixels/detectors in the
active-pixel array, the DSCFO probe 110 can take up to
-1,439,670 measurements per second. The high sampling
rate allows several possible optimal modes to operate. For
example, measurement accuracy can be increased by utilizing averaging data from multiple pixel/detector measurements, thereby reducing the impact of stochastic variation
and sensor noise. Rapid multiple-charmel measurements at
different S-D distances enable the quantification of tissue
hemodynamic heterogeneity at varying regions/depths of the
head and reduction of partial volume artifacts from the scalp
and skull. And pulsed operation can be employed in a
manner that allows measurements to be taken intermittently
(e.g., using a ½4 duty cycle), thus significantly reducing
power consumption and heat production. Other small-size,
low-power, and/or high-sensitive CMOS sensors may be
utilized in the DSCFO probe, such as NanEye (AWAIBA,
Germany) or Spy Camera (Adafruit Industries, New York) to
further reduce the probe size and heat production and to
increase the detection sensitivity/depth.
The S-D distances may range between a first distance Dl
and a second distance D2. These first and second distances
Dl, D2 may be characterized as the distances between a
given laser diode 112a, 112b and a given detector 146a,
146b of the bare imaging device 114. As noted above, these
detectors 146a, 146b may comprise a given 7x7 pixel region
of the CMOS chip. In the illustrated embodiment of FIG. 16,
the S-D distances may be 10 mm and 15 mm, respectively.
S-D distances such as these allow measurements to be taken
at sufficient depths (i.e. approximately half of the S-D
distance, or 5-7.5 mm with the illustrated S-D distances) to
penetrate the superficial layers of an infant's frontal scalp
and skull. Moreover, multiple S-D distance measurements
by the DSCFO probe allows for the reduction of partial
volume artifacts from the top layer tissues using the linear
layer algorithms noted above.
By alternatively measuring relative changes in intensities
of given detectors at the two wavelengths, relative changes
in tissue absorption coefficients li.µjA) can be extracted
based on a dual-wavelength NIRS method, assuming that
the tissue scattering coefficient µ)(A) is kuown from the
literature. This method is described in the following publication, the disclosure of which is incorporated herein by
reference: Shang Y, Zhao, Y. Cheng, Y Dong L, Irwin D, Yu
G, Portable optical tissue flow oximeter based on diffuse
correlation spectroscopy, Optics Letters, 34(22), 3556-3558
(2009). Concentration changes of li.[HbO 2 ] and li.[Hb] can
be determined from the measured li.µjA) at the two wavelengths and li.StO 2 (%) can be calculated from the ratio of
li.[HbO 2 ]/([HbO2 ]+[Hb ]).
By alternatively measuring intensities of given detectors
at the two wavelengths and at multiple different S-D distances, tissue absorption coefficients µjA) can be extracted
based on a spatially-resolved (multiple S-D distances) NIRS
method, assuming that the cerebral tissue scattering coefficient µ)(A) is kuown from the literature. This method is
described in the following publications, the disclosures of
which are incorporated herein by reference: 1) Cheng R,
Shang Y, Hayes D, Saha S P and Yu G, Noninvasive optical
evaluation of spontaneous low frequency oscillations in
cerebral hemodynamics. Neuroimage, 2012; 62:1445-1454;
and 2) Liu H, Boas DA, Zhang Y, Yodh AG and Chance B,
Determination of optical properties and blood oxygenation
in tissue using continuous NIR light, Phys Med Biol., 1995;
40:1983-93. Concentrations of [HbO 2 ] and [Hb] can be
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determined from the measured µjA) at the two wavelengths
While the invention has been described with reference to
and StO 2 (%) can be calculated from the ratio of [HbO 2]/
specific examples, it will be understood that numerous
([HbO 2] +[Hb ]).
variations, modifications and additional embodiments are
Averaged blood flow index (BFI) at the two wavelengths
possible, and all such variations, modifications, and embodirepresents a CBF value. The relative change in CMRO 2 can 5 ments are to be regarded as being within the spirit and scope
be calculated based on Fick's law, rCMRO 2=rCBFx(lof the invention. Also, the drawings, while illustrating the
StO2)/(l-StO26ase), where StO 26 ase is the baseline StO 2
inventive concepts, are not to scale, and should not be
before physiological changes. This method is described in
limited to any particular sizes or dimensions. Accordingly, it
the following publications, the disclosures of which are
is intended that the present disclosure not be limited to the
incorporated herein by reference: 1) Shang Y, Zhao Y, Cheng 1o
described embodiments, but that it has the full scope defined
R, Dong L, Irwin D and Yu G. Portable optical tissue flow
by the language of the following claims, and equivalents
oximeter based on diffuse correlation spectroscopy, Opt
thereof.
Lett., 2009; 34:3556-3558; 2) Shang Y, Cheng R, Dong L,
Ryan S J, Saha S P and Yu G. Cerebral monitoring during
The invention claimed is:
carotid endarterectomy using near-infrared diffuse optical 15
1. A probe for use in measuring a hemodynamic parameter
spectroscopies and electroencephalogram, Phys Med Biol.,
deep within a tissue of a subject, said probe comprising:
2011; 56:3015-3032; 3) Cheng R, Shang Y, Hayes D, Saha
a light source comprising a laser diode for emitting
S P and Yu G. Noninvasive optical evaluation of spontaneous low frequency oscillations in cerebral hemodynamics,
near-infrared light into the tissue of the subject to
Neuroimage, 2012; 62:1445-1454; 4) Gurley K, Shang Y 20
provide point illumination; and
and Yu G. Noninvasive optical quantification of absolute
a detector comprising a two-dimensional pixel array
bloodflow, blood oxygenation, and oxygen consumption rate
adapted to contact the tissue of the subject and receive
in exercising skeletal muscle, J Biomed Opt., 2012;
diffuse light fluctuations reflected from the tissue to
17:075010; 5) Shang Y, Li T, Chen L, Lin Y, Toborek Mand
detect diffuse laser speckle contrast variations in the
Yu G. Extraction of diffuse correlation spectroscopy flow 25
tissue for measurement of the hemodynamic parameter;
index by integration of Nth-order linear model with Monte
wherein the light source and the detector are separated
by a known source-detector ("S-D") distance that is
Carlo simulation, Applied Physics Letters, 2014; 104:
193703; 6) Shang Y and Yu G. A Nth-order linear algorithm
approximately twice the desired penetration depth of
for extracting diffuse correlation spectroscopy blood flow
the light source in a tissue, the detector being connected
indices in heterogeneous tissues, Applied Physics Letters, 30
to a controller adapted to calculate a blood flow index
2014; 105 133702; 7) Cheng R, Shang Y, Wang SQ, Evans
from measured diffuse laser speckle contrast at the S-D
J M, Rayapati A, Randall D C and Yu G. Near-infrared
distance by a diffusive model with a multiple scattering
diffuse optical monitoring of cerebral blood flow and oxytheory, and further wherein said probe includes no
genation for the prediction of vasovagal syncope, J Biomed
optical cable.
Opt. 2014; 19; 8) Shang Y, Chen L, Toborek Mand Yu G. 35
2. The probe of claim 1, further including a retainer for
Diffuse optical monitoring of repeated cerebral ischemia in
retaining the light source laser diode and the detector at the
mice. Opt Express. 2011; 19:20301-20315; 9) Chen L,
known S-D distance fixed positions relative to each other.
Shang Y, Sipos K E, Saatman K E, Yu G and Toborek M.
3. The probe of claim 2, wherein the retainer is selected
Novel experimental model for repeated forebrain ischemiafrom the group consisting of a block, a plate, a film or a foam
reperfusion, Journal of experimental stroke and translational 40 pad.
medicine, 2012; 5:1-10.
4. The probe of claim 1, wherein the laser diode produces
As further illustrated in FIG. 16, the DSCFO probe may
a coherence length in human tissue larger than 10 cm and 1
include a thermocouple 115. This may be used for evaluating
ill.
the temperature of the surface of the tissue being evaluated.
5. The probe of claim 1, wherein the detector is adapted
A retainer 116 may be provided for maintaining relative 45 to receive the light reflected from the tissue without passing
position between the laser diodes 112a, 112b and the bare
through any lenses prior to receiving the light.
imaging device 114. The retainer 116 may be in the form of
6. The probe of claim 1, wherein the known S-D distance
is a distance of between O mm-20 mm.
a pad, a plate, a block, or a film, which may include one or
more receivers for receiving the laser diodes 112a, 112b and
7. The probe of claim 1, wherein the controller is remote
the bare imaging device 114. For example, the retainer 116 50 from the source and detector.
may comprise a foam pad with an aperture or retaining space
8. The probe of claim 1, wherein the controller is confor each of the laser diodes 112a, 112b and the bare imaging
nected to the source and detector via electrical wires.
device 114.
9. The probe of claim 1, wherein the controller is conA 3D printer may be used to fabricate the probe. Each
nected to the source and detector via electrical wires.
sensor element (e.g. the CMOS chip and the thermocouple) 55
10. The probe of claim 1, wherein the two-dimensional
and the laser diodes may be assembled with rubber-like
pixel array comprises a bare charge coupled device.
photopolymers (e.g. PolyJet photopolymers) to form a soft
11. The probe of claim 1, wherein the two-dimensional
surface that is suitable for long-term use. In one aspect, the
pixel array comprises a complementary metal oxide semisoft surface may be adapted to conform to the surface
conductor.
curvature of a neuronal forehead.
60
12. The probe of claim 1, further comprising an optical
As can be seen in FIG. 17, in use, the DSCFO probe 110
lens.
may be attached to a fixing element 118, such as medical
13. The probe of claim 1, wherein the S-D distance is such
tape, a bandage, or other adhesive strip, for retaining the
that the probe can measure blood flow approximately up to
probe in contact with the surface of the tissue. The DSCFO
10 mm below tissue surface.
probe 110 may be connected to a controller, such as a 65
14. A method of measuring at least one hemodynamic
computer, a laptop, or other mobile device, and powerparameter within a tissue of a subject, said method comsupply circuitry elements.
prising:

US 10,842,422 B2
17

18

placing the probe of claim 1 on surface tissue above the
skull of the subject, wherein the two-dimensional pixel
array of the detector is in contact with the tissue of the
subject;
emitting near-infrared light from the laser diode onto
tissue of the subject, said near-infrared light not
received through an optical cable;
and
measuring diffuse light from the tissue and calculating
through the controller a blood flow index from measured diffuse laser speckle contrast at the S-D distance
by a diffusive model with a multiple scattering theory.
15. The method of claim 14, further including the step of
emitting light at a second wavelength from a second laser
diode within the light source into the tissue, and wherein the
measuring step comprises measuring reflected diffuse laser
speckle contrast reflected from the tissue from the first laser
diode and the second laser diode, alternatively.
16. The method of claim 14, further including the step of
attaching each of the light sources and the detector to a
retainer in order to maintain the S-D distance.
17. The method of claim 16, wherein the S-D fixed
distance is between O mm and 20 mm.
18. A probe for use in measuring at least one hemodynamic parameter within a tissue of a subject, said probe
comprising:
a light source comprising a first laser diode adapted for
emitting near-infrared light into the tissue of the subject
at a first wavelength to provide a first point of illumi-

nation and a second laser diode adapted for emitting a
second point of illumination into the tissue of the
subject at a second wavelength different from the first
laser diode;
a detector comprising a two-dimensional pixel array
adapted to contact the tissue of the subject and receive
diffuse light reflected from the tissue to detect diffuse
laser speckle contrast variations in the tissue for measurement of the hemodynamic parameter; and
a retainer adapted to receive and maintain a known
source-detector ("S-D") distance from each of the first
laser diode and the second laser diode to the detector,
said retainer including a contact surface adapted to
contact the tissue of the subject;
wherein the retainer is adapted to maintain the source and
detector in contact with the tissue with no lens therebetween.
19. The probe of claim 18, wherein the probe includes no
optical cable.
20. The probe of claim 18, wherein the two-dimensional
pixel array comprises a charge coupled device.
21. The probe of claim 18, wherein the two-dimensional
pixel array comprises a bare complementary metal oxide
semiconductor.
22. The probe of claim 18, wherein the S-D distance is
such that the probe can measure blood flow approximately
up to 10 mm below tissue surface.
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